CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 7 No. 2
 

Breast Cancer Diagnosed After Childbirth May Be More Severe

February 1, 1998

WASHINGTON—Studies indicating an increased risk of breast cancer in the years immediately after giving birth were not borne out by an investigation at the Fred Hutchinson Cancer Research Center, Seattle, Linda S. Cook, PhD, reported at the Department of Defense’s “Era of Hope” breast cancer conference. A second study presented at the meeting shows that when breast cancers do occur immediately after childbirth, they are likely to be more severe.

In her presentation, Dr. Cook said that “there is no consistent pattern of elevated breast cancer risk for women with recent term pregnancies in any age group.”

Dr. Cook and her colleagues did a case-control study of 1,023 women, aged 21 to 45, diagnosed with in situ or invasive breast cancer since 1983 in three counties in western Washington state. They found little association with recent pregnancy and increased risk of developing breast cancer.

Among multiparous women of the same age, parity, and age at first term birth, there was no increased risk for those who had their last birth late in their reproductive life, compared with those who had their last term pregnancy earlier, Dr. Cook said.

More Severe Disease

While Dr. Cook found that there was no greater likelihood of diagnosis in the years right after giving birth, Professor Mads Melbye, of the Danish Epidemiology Science Centre, Copenhagen, said that those women who are diagnosed with breast cancer at that time may have more severe disease.

Dr. Melbye’s group looked at records of 5,652 women with breast cancer, aged 45 years or less at the time of diagnosis. The registry included data on reproductive history, tumor size, and nodal status at diagnosis.

“A diagnosis of breast cancer within 2 years after birth is associated with particularly poor survival irrespective of the stage of the disease at debut,” he said. The difficulty of diagnosing breast cancer in young women in general, and pregnant and lactating women in particular, because of the density of the mammary glands, is reflected in a significant diagnostic delay among these patients.”

Prof. Melbye said that the tendency for recently pregnant women to have more advanced disease could, at least to some extent, be caused by delayed diagnosis. “However, our detailed information on each woman’s tumor characteristics allowed us to adjust for this,” Prof Melbye said.

Independent of the potential influence of delayed cancer diagnosis, the study showed that a recent birth before the diagnosis of breast cancer conferred an increased risk of dying of the disease of about 60%, compared with the mortality risk of other women with breast cancer.

“The negative effect of recent pregnancy was pronounced both in low-risk women who did not receive adjuvant treatment and in high-risk women who did receive adjuvant therapy. “Therefore, it is not known whether more intensive adjuvant treatment will change the course of the disease in these patients,” Prof. Melbye said, adding that “these findings need to be considered in counseling such patients and in deciding on adjuvant treatment.”

Prof. Melbye suggests that pregnancy history be recorded for premenopausal breast cancer patients in prospective clinical trials so that response to adjuvant treatment according to time since last childbirth can be assessed.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy